Author:
Delorme Vincent,Dhouib Rabeb,Canaan Stéphane,Fotiadu Frédéric,Carrière Frédéric,Cavalier Jean-François
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference94 articles.
1. Carrière F, Renou C, Ransac S, Lopez V, De Caro J, Ferrato F, et al. Inhibition of gastrointestinal lipolysis by Orlistat during digestion of test meals in healthy volunteers. Am J Physiol Gastrointest Liver Physiol. 2001;281(1):G16–28.
2. Tiss A, Lengsfeld H, Verger R. A comparative kinetic study on human pancreatic and Thermomyces lanuginosa lipases: inhibitory effects of tetrahydrolipstatin in the presence of lipid substrates. J Mol Catal B Enzym. 2010;62:19–26.
3. Lengsfeld H, Beaumier-Gallon G, Chahinian H, De Caro A, Verger R, Laugier R, et al. Physiology of gastrointestinal lipolysis and therapeutical use of lipases and digestive lipase inhibitors. In: Müller G, Petry S, editors. Lipases and phospholipases in drug development. Weinheim: Wiley-VCH; 2004. p. 195–223.
4. Ballinger A, Peikin S. Orlistat: its current status as an anti-obesity drug. Eur J Pharmacol. 2002;440(2–3):109–17.
5. Kopelman P, Bryson A, Hickling R, Rissanen A, Rossner S, Toubro S, et al. Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients. Int J Obes Lond. 2007;31(3):494–9.
Cited by
152 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献